Viz.ai's new Product Marketing Manager will own the Viz Pulmonary Suite and the asset library sales relies on. The suite was launched for COPD, lung nodules and PE, but on viz.ai it has one page, every resource linked from it is about PE, PE itself sits under the Vascular Suite, and the sitemap has no COPD or nodule page, brochure, case study or blog post. A pulmonologist or service-line leader looking for COPD or nodule follow-up finds nothing to read or share.
First action
List the claims already cleared for COPD and nodules and draft the two page outlines.
How to measure it
Demo requests from pulmonary pages
- Now
- –
- Target
- 2x the current rate
- By
- 2 quarters
Steps
Inventory
Cleared indications, approved claims and live sites per pathway.
Senior Product Manager (Pulmonary) 1 week
Outline pages
COPD and nodule pathway pages, one structure for both.
Product Marketing Manager 3 days
Write the one-pager
Pulmonary Suite one-pager in the existing brochure format.
Product Marketing Manager 1 week
Clinical and regulatory review
Every claim checked against labeling and evidence.
Regulatory Affairs 2 weeks
Fix navigation
PE linked inside the Pulmonary Suite; new pages in the menu.
Web Manager 2 days
Book a webinar
A customer pulmonologist on care coordination workflow.
Product Marketing Manager 1 month
Arm sales
Pages and one-pager in the pulmonary sales kit.
Clinical Sales Specialist, Pulmonary 1 week
Measure
Visits, demo requests and influenced pipeline by pathway.
Marketing Operations Manager monthly
Why it works
Build the pulmonary library the Clinical Sales Specialist can sell with: one page each for COPD and lung nodule follow-up (what the pathway does, who on the care team uses it, EHR integration, cleared indications only), a Pulmonary Suite one-pager to match the HCM, ACS and amyloidosis ones, a webinar with a customer pulmonologist, and a case study as soon as a site has results. Link PE into the suite navigation. Every page goes through clinical and regulatory review before it goes live.
Buyers in a new service line need proof in their own condition. The pages also give search and AI assistants something to cite when people look for COPD or nodule care coordination.
Ready to use
ChecklistPulmonary library launch list
[ ] COPD pathway page [ ] Lung nodule follow-up page [ ] PE linked inside the Pulmonary Suite menu [ ] Pulmonary Suite one-pager [ ] Customer pulmonologist webinar [ ] First pulmonary case study [ ] Clinical and regulatory sign-off on each asset [ ] Assets added to the pulmonary sales kit
Risks and how to handle them
Claims beyond cleared indications
Regulatory sign-off on every page and asset; use only published or cleared statements.
Not enough live results yet
Lead with workflow and integration; add case studies as sites report.
Evidence
- HiringProduct Marketing Manager (remote US, posted October 19, 2026): will "own commercial go-to-market strategy for our AI-powered SaMD solutions, with accountability for Viz Pulmonary Suite", "Build and maintain the core marketing asset library (webinars, blogs, podcasts, brochures, sales enablement supports, etc) that the commercial team relies on", "Set positioning and messaging strategy for distinct functional audiences", plan campaigns with demand generation and work with "Product, Sales, Clinical, Regulatory, Customer Success, and Life Sciences teams".Source
- Your websiteThe Viz Pulmonary Suite page (/pulm) says the suite covers "COPD, PE, and lung nodules" and quotes figures for each, but the four resources it links (a clinical validation study, a blog post, the launch release and a webinar) are all about pulmonary embolism or the suite as a whole. In the site navigation, Pulmonary Embolism sits under the Vascular Suite and the Pulmonary Suite has a single page; the Neuro Suite has six condition pages and the Cardio Suite four.Source
- Your websiteSitemap (checked October 22, 2026): 573 URLs including 15 brochures, 8 case studies, 59 webinars, 21 podcasts and 74 blog posts. Brochures and one-pagers exist for HCM, ACS, cardiac amyloidosis, aortic and PE modules, radiology and stroke, but none for the Pulmonary Suite. No page, brochure, case study or blog post has COPD, nodule, AATD or asthma in its address. All 8 case studies are stroke, rare-disease or platform stories.Source
- HiringSenior Product Manager, Pulmonary (posted October 16, 2026), a pulmonologist role: the focus "starts with COPD, AATD, and broader pulmonary clinic workflows, including asthma, within a portfolio that also includes incidental pulmonary nodules and lung cancer screening. Some of this work is live with customers; some is still being built and validated." A Clinical Sales Specialist, Pulmonary (posted October 5) will "Leverage clinical data and outcomes studies to educate stakeholders" and work with Marketing on "targeted sales strategies and campaigns for pulmonology service lines".Source
- News coverageViz.ai launched the Viz Pulmonary Suite on May 14, 2026, for COPD, lung nodules and pulmonary embolism, integrated with the EHR; the release cites a single-center Viz PE study and quotes a pulmonologist from Monogram Health. Viz.ai showed it at the ATS conference.Source